Canada Life’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $236K | Sell |
8,293
-13,465
| -62% | -$383K | ﹤0.01% | 1694 |
|
2025
Q1 | $644K | Buy |
21,758
+2,745
| +14% | +$81.2K | ﹤0.01% | 1556 |
|
2024
Q4 | $552K | Sell |
19,013
-1,376
| -7% | -$39.9K | ﹤0.01% | 1619 |
|
2024
Q3 | $938K | Hold |
20,389
| – | – | ﹤0.01% | 1531 |
|
2024
Q2 | $834K | Buy |
20,389
+11,737
| +136% | +$480K | ﹤0.01% | 1541 |
|
2024
Q1 | $221K | Hold |
8,652
| – | – | ﹤0.01% | 1817 |
|
2023
Q4 | $78K | Hold |
8,652
| – | – | ﹤0.01% | 1993 |
|
2023
Q3 | $55K | Buy |
8,652
+6,279
| +265% | +$39.9K | ﹤0.01% | 2058 |
|
2023
Q2 | $26K | Hold |
2,373
| – | – | ﹤0.01% | 2101 |
|
2023
Q1 | $36K | Buy |
2,373
+476
| +25% | +$7.22K | ﹤0.01% | 2114 |
|
2022
Q4 | $42K | Hold |
1,897
| – | – | ﹤0.01% | 2107 |
|
2022
Q3 | $31K | Hold |
1,897
| – | – | ﹤0.01% | 2181 |
|
2022
Q2 | $28K | Hold |
1,897
| – | – | ﹤0.01% | 2194 |
|
2022
Q1 | $37K | Hold |
1,897
| – | – | ﹤0.01% | 2229 |
|
2021
Q4 | $45K | Buy |
1,897
+967
| +104% | +$22.9K | ﹤0.01% | 2202 |
|
2021
Q3 | $23K | Hold |
930
| – | – | ﹤0.01% | 2403 |
|
2021
Q2 | $23K | Hold |
930
| – | – | ﹤0.01% | 2460 |
|
2021
Q1 | $20K | Hold |
930
| – | – | ﹤0.01% | 2507 |
|
2020
Q4 | $24K | Buy |
+930
| New | +$24K | ﹤0.01% | 2507 |
|